XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2
Segments (Tables)
6 Months Ended
Jun. 30, 2022
Segments  
Revenue and Pre-tax Income by Segment

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Total

 

(Dollars in millions)

​

Software

​

Consulting

​

Infrastructure

​

Financing

​

Segments

 

For the three months ended June 30, 2022:

 

​

  

 

​

  

 

​

  

 

​

  

 

​

  

​

Revenue

​

$

6,166

​

$

4,809

​

$

4,235

​

$

146

​

$

15,355

​

Pre-tax income from continuing operations

​

$

1,375

​

$

343

​

$

757

​

$

102

​

$

2,577

​

Revenue year-to-year change

​

 

6.4

%  

 

9.8

%  

 

19.0

%  

 

(29.9)

%  

 

10.1

%

Pre-tax income year-to-year change

​

 

29.9

%  

 

26.9

%  

 

54.8

%  

 

(22.4)

%  

 

32.2

%

Pre-tax income margin

​

 

22.3

%  

 

7.1

%  

 

17.9

%  

 

69.7

%  

 

16.8

%

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the three months ended June 30, 2021*:

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

Revenue

​

$

5,795

​

$

4,378

​

$

3,560

​

$

209

​

$

13,941

​

Pre-tax income from continuing operations

​

$

1,059

​

$

270

​

$

489

​

$

131

​

$

1,949

​

Pre-tax income margin

​

 

18.3

%  

 

6.2

%  

 

13.7

%  

 

63.0

%

 

14.0

%

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Total

 

(Dollars in millions)

​

Software

​

Consulting

​

Infrastructure

​

Financing

​

Segments

 

For the six months ended June 30, 2022:

 

​

  

 

​

  

 

​

  

 

​

  

 

​

  

​

Revenue

​

$

11,938

​

$

9,637

​

$

7,453

​

$

300

​

$

29,328

​

Pre-tax income from continuing operations

​

$

2,509

​

$

691

​

$

956

​

$

186

​

$

4,342

​

Revenue year-to-year change

​

 

9.2

%  

 

11.5

%  

 

8.8

%  

 

(28.0)

%  

 

9.3

%

Pre-tax income year-to-year change

​

 

46.2

%  

 

26.3

%  

 

22.5

%  

 

(18.9)

%  

 

32.6

%

Pre-tax income margin

​

 

21.0

%  

 

7.2

%  

 

12.8

%  

 

62.0

%  

 

14.8

%

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the six months ended June 30, 2021*:

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

Revenue

​

$

10,933

​

$

8,641

​

$

6,853

​

$

417

​

$

26,843

​

Pre-tax income from continuing operations

​

$

1,717

​

$

547

​

$

780

​

$

229

​

$

3,274

​

Pre-tax income margin

​

 

15.7

%

 

6.3

%

 

11.4

%

 

55.0

%

 

12.2

%

Reconciliation of segment revenue and pre-tax income to IBM as reported

Reconciliations to IBM as Reported:

​

​

​

​

​

​

​

​

(Dollars in millions)

    

    

​

    

    

​

 

For the three months ended June 30:

​

2022

​

2021*

 

Revenue:

 

​

  

 

​

  

​

Total reportable segments

​

$

15,355

​

$

13,941

​

Other‒divested businesses

​

 

162

​

 

197

​

Other revenue

​

 

18

​

 

80

​

Total consolidated revenue

​

$

15,535

​

$

14,218

​

​

​

​

​

​

​

​

​

Pre-tax income from continuing operations:

​

 

  

​

 

  

​

Total reportable segments

​

$

2,577

​

$

1,949

​

Amortization of acquired intangible assets

​

 

(458)

​

 

(456)

​

Acquisition-related (charges)/income

​

 

(2)

​

 

(18)

​

Non-operating retirement-related (costs)/income

​

 

(192)

​

 

(317)

​

Kyndryl-related impacts**

​

​

(145)

​

 

—

​

Eliminations of internal transactions

​

 

(4)

​

 

5

​

Other‒divested businesses

​

 

160

+

 

(50)

​

Unallocated corporate amounts and other

​

 

(215)

​

 

(202)

​

Total pre-tax income from continuing operations

​

$

1,722

​

$

912

​

*

Recast to conform to current year presentation.

** Refer to note 8, “Financial Assets & Liabilities,” for additional information.

+ Includes a gain from the sale of the company’s healthcare software assets. Refer to note 6, “Acquisitions & Divestitures.”

Reconciliations to IBM as Reported:

​

​

​

​

​

​

​

​

​

(Dollars in millions)

    

    

​

    

    

​

 

For the six months ended June 30:

​

2022

​

2021*

 

Revenue:

 

​

  

 

​

  

​

Total reportable segments

​

$

29,328

​

$

26,843

​

Other‒divested businesses

​

 

316

​

 

394

​

Other revenue

​

 

88

​

 

167

​

Total consolidated revenue

​

$

29,732

​

$

27,405

​

​

​

​

​

​

​

​

​

Pre-tax income from continuing operations:

​

 

  

​

 

  

​

Total reportable segments

​

$

4,342

​

$

3,274

​

Amortization of acquired intangible assets

​

 

(919)

​

 

(903)

​

Acquisition-related charges

​

 

(9)

​

 

(34)

​

Non-operating retirement-related (costs)/income

​

 

(394)

​

 

(649)

​

Kyndryl-related impacts**

​

​

(367)

​

​

—

​

Eliminations of internal transactions

​

 

(15)

​

 

(4)

​

Other‒divested businesses

​

 

109

+

 

(65)

​

Unallocated corporate amounts

​

 

(403)

​

 

(464)

​

Total pre-tax income from continuing operations

​

$

2,345

​

$

1,155

​

*

Recast to conform to current year presentation.

**

Refer to note 8, “Financial Assets & Liabilities,” for additional information.

+ Includes a gain from the sale of the company’s healthcare software assets. Refer to note 6, “Acquisitions & Divestitures.”